References
- Beasley RP Hwang LY Lin CC Chien CS Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan Lancet 1981 2 8256 1129 1133 6118576
- Suzuki F Suzuki Y Tsubota A Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy J Hepatol 2002 37 6 824 830 12445424
- Marcellin P Chang TT Lim SG Adefovir Dipivoxil 437 Study Group Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 2003 348 9 808 816 12606735
- Ono A Suzuki F Kawamura Y Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients J Hepatol 2012 57 3 508 514 22659518
- Suzuki F Arase Y Suzuki Y Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan J Gastroenterol 2012 47 7 814 822 22361865
- Zoulim F Locarnini S Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 2009 137 5 1593 1608 19737565
- Yang H Qi X Sabogal A Miller M Xiong S Delaney WE Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV Antivir Ther 2005 10 5 625 633 16152756
- Heathcote EJ Marcellin P Buti M Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B Gastroenterology 2011 140 1 132 143 20955704
- Snow-Lampart A Chappell B Curtis M No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus Hepatology 2011 53 3 763 773 21374657
- Marcellin P Gane E Buti M Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 2013 381 9865 468 475 23234725
- Gordon SC Krastev Z Horban A Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load Hepatology 2013 58 2 505 513 23364953
- Kitrinos KM Corsa A Liu Y No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B Hepatology 2014 59 2 434 442 23939953
- van Bömmel F de Man RA Wedemeyer H Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues Hepatology 2010 51 1 73 80 19998272
- Suzuki F Akuta N Suzuki Y Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants J Med Virol 2006 78 3 341 352 16419116
- Sheldon J Camino N Rodés B Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir Antivir Ther 2005 10 6 727 734 16218172
- Delaney WE Ray AS Yang H Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus Antimicrob Agents Chemother 2006 50 7 2471 2477 16801428
- Qi X Xiong S Yang H Miller M Delaney WE In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents Antivir Ther 2007 12 3 355 362 17591025
- Qin B Budeus B Cao L The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir Antiviral Res 2013 97 2 93 100 23261845
- Petersen J Ratziu V Buti M Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study J Hepatol 2012 56 3 520 526 22037226
- Kim YJ Sinn DH Gwak GY Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures World J Gastroenterol 2012 18 47 6996 7002 23322999
- Seto WK Liu K Wong DK Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment J Hepatol 2013 59 4 709 716 23792029
- Karatayli E Idilman R Karatayli SC Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir Antivir Ther 2013 18 1 77 85 22878399
- Okamoto H Tsuda F Sakugawa H Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes J Gen Virol 1988 69 10 2575 2583 3171552